1.Updated diagnosis and management of chronic orchialgia.
National Journal of Andrology 2016;22(3):195-199
Chronic orchialgia (CO) is a common complaint in urology or andrology. Due to its complicated pathogenesis, the diagnosis and treatment of CO are quite challenging. Based on different etiologies, CO can be idiopathic or secondary. Idiopathic CO accounts for approximately 50% of the cases and is probably associated with Wallerian degeneration in the spermatic cord nerves and peripheral sensitization. Secondary CO can be attributed to direct causes and its treatment focuses on the pathologic condition identified. The main methods for the treatment of CO include conservative and surgical strategies, among which microsurgical spermatic cord denervation ( MSCD) is an effective and minimally invasive option, while orchiectomy is but the last alternative when no other means is left.
Denervation
;
methods
;
Humans
;
Male
;
Microsurgery
;
Orchiectomy
;
Pain
;
diagnosis
;
etiology
;
Pain Management
;
methods
;
Spermatic Cord
;
innervation
;
Testicular Diseases
;
diagnosis
;
etiology
;
therapy
2.Apoptosis in male germ cells induced by testicular denervation.
Yong-guang GONG ; Yu-ru YANG ; Wei ZHANG ; Min GU ; Chang-jun YIN
National Journal of Andrology 2006;12(11):968-973
OBJECTIVETo evaluate the role of spermatic nerves in the regulation of spermatogenesis.
METHODSFifty-four mature SD male rats (350-375 g) were randomized into a sham operation group (SO) and three experiment groups, and the latter underwent bilateral surgical removal of the superior spermatic nerve (SSN) or/and the inferior spermatic nerve (ISN). The animals were killed 1 month and 2 months after the operation. HE stain was used to observe spermatogenesis. Transmission electron microscopy and terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) were employed to detect apoptosis.
RESULTSImpaired spermatogenesis was observed 2 months after the operation, with only Sertoli cells and a few spermatogonia remaining in the regressed tubules in all the treatment groups. The abnormal tubules in the SSN, ISN and SSN + ISN denervated testes accounted for (13.25 +/- 2.03)%, (11.0 +/- 4.36)% and (34.17 +/- 3.78)% respectively. Chromosome condensation and fragmentation in the germ cells were observed under the electron transmission microscope in all the denervated testes. TUNEL showed the spermatogonia and Leydig cells to be apoptotic in all the denervated testes and the incidence of the apoptotic cells in the SSN + ISN denervated testes was significantly higher than in the SSN or ISN denervated ones.
CONCLUSIONSpermatic nerves play an important role in spermatogenesis.
Animals ; Apoptosis ; Denervation ; Germ Cells ; pathology ; Leydig Cells ; pathology ; Male ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Spermatic Cord ; innervation ; Spermatogenesis ; physiology ; Spermatogonia ; pathology ; Testis ; innervation
3.Validation of targeted microsurgical spermatic cord denervation: comparison of outcomes to traditional complete microsurgical spermatic cord denervation.
Asian Journal of Andrology 2019;21(4):319-323
The aim of this study was to validate the effectiveness of targeted microsurgical spermatic cord denervation (MSCD) of the trifecta nerve complex in comparison to traditional full MSCD with complete skeletonization of the spermatic cord in men with chronic orchialgia. Retrospective chart review was performed by a single fellowship-trained microsurgeon between 2011 and 2016. Patients had follow-ups at 6 weeks, 6 months, and 1 year postoperatively. Thirty-nine men with chronic orchialgia underwent full MSCD between 2011 and 2013. In July 2013, after the publication of an anatomic study with identification of Wallerian degeneration of the trifecta nerve complex in men with chronic orchialgia, the technique was changed to targeted MSCD. From July 2013 to March 2016, 43 men underwent targeted MSCD. When comparing the full MSCD group to the targeted MSCD group, there was no significant difference in resolution of pain (66.7% vs 69.8%, P = 0.88), no difference in partial relief of pain (17.9% vs 23.3%, P = 0.55), and no difference in failure to respond rates (15.4% vs 7.0%, P = 0.22) between the two groups. There was no difference in mean change of visual analog pain scale scores between the two groups (P = 0.27). Targeted MSCD had a shorter operative time (53 min vs 21 min, P = 0.0001). Targeted MSCD offers patients comparable outcomes to traditional full MSCD, with a shorter operative time, a less technically challenging surgery, and potentially less risk to cord structures which should be preserved.
Adult
;
Aged
;
Denervation/methods*
;
Humans
;
Male
;
Microsurgery/methods*
;
Middle Aged
;
Pain/surgery*
;
Spermatic Cord/innervation*
;
Testicular Diseases/surgery*
;
Treatment Outcome
;
Young Adult